BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10703880)

  • 1. Hypertension aggregates in families of kidney stone patients with high urinary excretion of uric acid.
    Tisler A; Pierratos A; Honey JD; Bull SB; Logan AG
    J Hypertens; 1999 Dec; 17(12 Pt 2):1853-8. PubMed ID: 10703880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High urinary excretion of uric acid combined with high excretion of calcium links kidney stone disease to familial hypertension.
    Tisler A; Pierratos A; Honey JD; Bull SB; Rosivall L; Logan AG
    Nephrol Dial Transplant; 2002 Feb; 17(2):253-9. PubMed ID: 11812875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease.
    Mente A; Honey RJ; McLaughlin JM; Bull SB; Logan AG
    J Am Soc Nephrol; 2006 Sep; 17(9):2567-75. PubMed ID: 16855017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the urinary microbiome in kidney stone patients with hypertension.
    Liu F; Zhang N; Jiang P; Zhai Q; Li C; Yu D; Wu Y; Zhang Y; Lv L; Xu X; Feng N
    J Transl Med; 2020 Mar; 18(1):130. PubMed ID: 32183836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of urate in renal calcium stone disease and in renal tubular acidification disturbances.
    Fellström B; Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    J Urol; 1982 Mar; 127(3):589-92. PubMed ID: 7062444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary excretion of calcium, magnesium and uric acid in kidney stone patients, their asymptomatic relatives and healthy subjects].
    González-Calvin JL; Montero García M; García Valdecasas J; Luna J; Raya Muñoz J; Peña Angulo JF; Peña Yáñez A
    Rev Clin Esp; 1981 Feb; 160(4):247-50. PubMed ID: 7268117
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.
    Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K
    Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis?
    Hartman C; Friedlander JI; Moreira DM; Leavitt DA; Hoenig DM; Smith AD; Okeke Z
    Urology; 2015 Mar; 85(3):539-43. PubMed ID: 25733263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid saturation in calcium nephrolithiasis.
    Coe FL; Strauss AL; Tembe V; Le Dun S
    Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic hypercalciuria and hyperuricosuria: family prevalence of nephrolithiasis.
    Polito C; La Manna A; Nappi B; Villani J; Di Toro R
    Pediatr Nephrol; 2000 Oct; 14(12):1102-4. PubMed ID: 11045395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of nutritional status, laboratory parameters and dietary patterns upon urinary acid excretion in calcium stone formers.
    Tessaro CZW; Ramos CI; Heilberg IP
    J Bras Nefrol; 2018; 40(1):35-43. PubMed ID: 29796583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.